Cargando...
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, enhanced immunity, and other desirable f...
Guardado en:
| Publicado en: | Matter |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7942141/ https://ncbi.nlm.nih.gov/pubmed/33723531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.matt.2021.02.025 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|